ENOV

Enovis CORP

Orthopedic, Prosthetic & Surgical Appliances & Supplies · SIC 3842CIK 1420800Held by 3 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$2.25B

Net Income FY2025

$(1.18B)

EPS (Basic, as reported)

$-20.75

Net Margin FY2025

-52.7%

ROE FY2025

-79.5%

Total Equity

$1.49B

Shares Out

58M

Business description

Enovis CORP — Orthopedic, Prosthetic & Surgical Appliances & Supplies. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 3,647 → 2,248 -5.2% CAGR

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021⚑FY2022FY2023FY2024FY2025

Revenue3,6471,9372,1933,3273,0713,8541,5631,7072,1082,248

Cost of revenue(2,501)(2,271)(2,534)(1,926)(1,783)(2,241)(694)(716)(927)(903)

Gross profit1,1461,0291,1331,4011,2881,6148699911,1811,345

Research & development————(34)(49)(61)(75)(91)(120)

Selling, general & administrative(825)(732)(818)(1,132)(1,087)(1,329)(773)(830)(1,027)(1,070)

Operating income23829237204162257(71)(66)(776)(1,124)

Interest expense(30)(41)(44)(120)(104)(73)(24)(20)(57)(35)

Other income (expense), net—————0226100

Pre-tax income208(12)1835058165(2)(67)(823)(1,159)

Income tax expense(63)(43)(30)(32)(6)(67)(36)(13)(4)(22)

Net income128151140(528)4372(13)(33)(825)(1,184)

EPS — basic$1.04$1.23$1.16($3.89)$0.31$0.47($0.25)($0.61)($14.93)($20.75)

EPS — diluted$1.04$1.22$1.16($3.89)$0.31$0.46($0.25)($0.61)($14.93)($20.75)

Shares outstanding — basic (M)12312312013613715354545557

Shares outstanding — diluted (M)12312312113713915654545557

Showing the latest 10 of 17 fiscal years.

⚑ Weighted-average shares changed ÷2.86 between FY2021 and FY2022 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.